Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez et autres
128 citationsThe Lancet Respiratory Medicine